Ombitasvir/Paritaprevir/Ritonavir
- Generic Name
- Ombitasvir/Paritaprevir/Ritonavir
- Indication
用于治疗成人基因1型慢性丙型肝炎，包括无肝硬化或伴代偿期肝硬化的患者。该治疗方案是全口服的、无干扰素、可联合或不联合利巴韦林。
Bioavailability of ABT-450 and ABT-267 With Ritonavir
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 16
- Registration Number
- NCT02052362
- Locations
- 🇬🇧
Site Reference ID/Investigator# 118615, Nottingham, United Kingdom
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
Phase 3
Completed
- Conditions
- Chronic Hepatitis C Infection
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 363
- Registration Number
- NCT02023099
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2021-07-30
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 171
- Registration Number
- NCT02023112
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
Phase 2
Completed
- Conditions
- Hepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis and Non-cirrhoticsHuman Immunodeficiency Virus Infection
- Interventions
- First Posted Date
- 2013-09-11
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 318
- Registration Number
- NCT01939197
An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
Phase 2
Completed
- Conditions
- Chronic Hepatitis C InfectionChronic Hepatitis C
- Interventions
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 38
- Registration Number
- NCT01911845
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Phase 2
Completed
- Conditions
- Chronic Hepatitis C Infection
- Interventions
- First Posted Date
- 2013-02-04
- Last Posted Date
- 2017-11-07
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 129
- Registration Number
- NCT01782495
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath